Koya Medical ("Koya"), a medical technology company advancing evidence-based therapies for venous and lymphatic disease, ...

A study by researchers at U.S. health insurance and medical services provider Kaiser Permanente, the Food is Medicine ...

DEEp OCEAN is a global trial designed to evaluate the investigational molecule bexicaserin for the treatment of seizures ...

Mean LDL-C at 6 months was 76.3 vs 85.6 mg/dL, yielding an adjusted difference of −6.62 mg/dL and higher attainment of LDL-C <50 mg/dL. Intervention uptake increased intensive and combination ...

Actinogen Medical Limited (ASX: ACW) today announces that results from its proof-of-concept trial, entitled “A phase 2 ...

Suzhou Ribo Life Science and subsidiary Ribocure Pharmaceuticals, collectively known as Ribo, has reported initial results from its Phase IIa clinical trial of vortosiran (RBD4059 ...

Families caring for loved ones with advanced dementia and severe agitation now have a new piece of clinical evidence to weigh ...

A study from researchers at top US health insurance and medical services provider Kaiser Permanente, the Food is Medicine ...

Introduction Stroke remains a leading cause of disability and mortality worldwide, with an urgent need for novel therapeutic strategies to improve recovery. Bupropion hydrochloride, a ...

A study from researchers at top US health insurance and medical services provider Kaiser Permanente, the Food is Medicine ...

Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that the first participant has been randomized and dosed in the global Phase IIb ...

Sickle cell disease remains a major public health challenge in India, particularly among tribal populations. According to ...